Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20210722 (AU)

191
Gene and protein biomarkers
35
Combination biomarkers
9
Complex biomarkers
697
Simple mutations
256
Variant groups
86
Protein expressions
90
Amplification deletions
189
Fusions and Rearrangements
5
Splice variants
5
Methylations
11
Germline mutations
21
Common cancers
53
T1
43
T2
82
T3
129
T4
8
R1
105
R2
16
Less common cancers
8
T1
8
T2
20
T3
42
T4
0
R1
6
R2
90
Rare cancers
35
T1
29
T2
47
T3
184
T4
7
R1
72
R2
© 2020, Garvan Institute of Medical Research & Omico Ltd.
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.